NURS6521 Approaches to health final exam

 Question 1
1 out of 1 points
What will the PMHNP most likely prescribe to a patient with psychotic aggression who
needs to manage the top-down cortical control and the excessive drive from striatal
hyperactivity?


Selected C.
Answer: Antipsychot
ics


 Question 2
1 out of 1 points
The PMHNP is selecting a medication treatment option for a patient who is exhibiting
psychotic behaviors with poor impulse control and aggression. Of the available
treatments, which can help temper some of the adverse effects or symptoms that are
normally caused by D2 antagonism?



Selected D.
Answer: Second-generation, atypical
antipsychotics


 Question 3
1 out of 1 points
The PMHNP is discussing dopamine D2 receptor occupancy and its association with
aggressive behaviors in patients with the student. Why does the PMHNP prescribe a
standard dose of atypical antipsychotics?


Selected C.
Answer: The doses are based on achieving 60% D2
receptor occupancy.


 Question 4
1 out of 1 points
Why does the PMHNP avoid prescribing clozapine (Clozaril) as a first-line treatment to the
patient with psychosis and aggression?


Selected A.
Answer: There is too high a risk of serious adverse
side effects.


 Question 5
1 out of 1 points
The PMHNP is caring for a patient on risperidone (Risperdal). Which action made by the
PMHNP exhibits proper care for this patient? </p?

, Selected C.
Answer: Titrating the dose by increasing it
every 5–7 days


 Question 6
1 out of 1 points
The PMHNP wants to prescribe Mr. Barber a mood stabilizer that will target aggressive
and impulsive symptoms by decreasing dopaminergic neurotransmission. Which mood
stabilizer will the PMHNP select?



Selected A.
Answer: Lithium
(Lithane)


 Question 7
1 out of 1 points
The parents of a 7-year-old patient with ADHD are concerned about the effects of
stimulants on their child. The parents prefer to start pharmacological treatment with a
non-stimulant. Which medication will the PMHNP will most likely prescribe?



Selected A.
Answer: Stratt
era



 Question 8
1 out of 1 points
The PMHNP understands that slow-dose extended release stimulants are most
appropriate for which patient with ADHD?


Selected A.
Answer: 8-year-old
patient



 Question 9
1 out of 1 points
A patient is prescribed D-methylphenidate, 10-mg extended-release capsules. What
should the PMHNP include when discussing the side effects with the patient?


Selected C.
Answer: The medication can affect your blood
pressure.

,  Question 10
1 out of 1 points
The PMHNP is teaching parents about their child’s new prescription for Ritalin. What will
the PMHNP include in the teaching?


Selected A.
Answer: The second dose should be taken
at lunch.



 Question 11
1 out of 1 points
A young patient is prescribed Vyvanse. During the follow-up appointment, which
comment made by the patient makes the PMHNP think that the dosing is being done
incorrectly?


Selected B.
Answer: “I am unable to fall asleep
at night.”



 Question 12
1 out of 1 points
A 14-year-old patient is prescribed Strattera and asks when the medicine should be
taken. What does the PMHNP understand regarding the drug’s dosing profile?



Selected B.
Answer: The patient will have one or two
doses a day.


 Question 13
0 out of 1 points
The PMHNP is meeting with the parents of an 8-year-old patient who is receiving an initial
prescription for D-amphetamine. The PMHNP demonstrates appropriate prescribing
practices when she prescribes the following dose:


Selected D.
Answer: The child will take 10–40
mg, daily.

 Question 14
1 out of 1 points